Stem Cell Network North Rhine Westphalia


Advanced search

Latest News

_The network "Ein Herz für NRW" presents current developments in Düsseldorf on 27.08.18 [more]

_Süddeutsche Zeitung deals with unproven therapies [more]


Just released: „Stem Cell Research. Current Scientific and Societal Developments“

Topics cover the current state of scientific and medical research, give an overview of international clinical trials, focus on ethical and legal aspects of research on human embryonic stem cells, discuss unproven stem cell therapies and include a bioethical debate about stem cell research.
Articles are authored by renowned experts in stem cell research and give recommendations for action for politics, science and economy. Several contributions are from researchers of the Stem Cell Network NRW.
Editor is the interdisciplinary research group called “Gene Technology Report” at the Berlin-Brandenburg Academy of Sciences and Humanities.

The entire book (only in German) as well as a short version (available in German and English) can be downloaded online.


The International Society for Stem Cell Research (ISSCR) tries to inform potential users (patients) of stem cell based treatments and suggests guidelines for clinical translation. Read more:

Guidelines for the Clinical Translation of Stem Cells

Patient Handbook on Stem Cell Therapies

Recent article about unproven therapies in China (Reuters).

Zoom in

Research Map NRW:

Thanks to various research approaches, a wide spectrum of scientific research into adult and embryo stem cells is covered in North Rhine Westphalia (NRW). The Stem Cell Network includes research facilities in Aachen, Bielefeld, Bochum, Bonn, Cologne, Düsseldorf, Essen, Münster and Witten/Herdecke. In addition, work on ethical, legal and sociological aspects of stem cell research is being conducted by various faculties at universities in Bochum, Bonn, Cologne, Duisburg, Düsseldorf, Essen, Hagen and Münster. For an overview of all these facilities, check out the Research Map NRW.



European Court of Justice bans patents of procedures based on human embryonic stem cells

After the final decision of the European Court of Justice from October 18, 2011 patents on biomedical inventions which include the use of human embryonic stem cells (hES) can't not be granted any longer.
This is effective no matter if the establishment of hES cells is part of the patent or not or those cells are imported from abroad - the only way it is allowed in Germany for example. Researchers interprete this decision as a set back for translation orientated research. More than 100 patents within Europe are affected by this.

Press release by the European Court of Justice
Presse release by Eurostemcell



Ergänzende Informationen

Latest publications from the network

Graffmann NNcube AWruck WAdjaye J. (2018Cell fate decisions of human iPSC-derived bipotential hepatoblasts depend on cell density. PLoS One. Jul 10;13(7):e0200416.

More publications


Stay informed with quarterly news about stem cells in our free newsletter.

Click here to subscribe

Follow us on social media

New rules for physicians offering stem cell treatments in Japan

The Japanese Society for Regenerative Medicine will establish a certification system for physicians with expertise and skills in regenerative medicine and for medical technicians adept at cell culturing techniques. read more

A Graphic Story of Stem Cells

A story about stem cell therapies from science discovery to working therapy.


New: For Patients

A new section of this website provides material to inform patients and caretakers.

read more.